Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 276
- Run by
- Fudan University
See details and how to joinNCT07492615 - No phaseTaking peopleA Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
- Where
- Jinhua, Lishui
- Age
- 18 years to 75 years
- People
- 30
- Run by
- The Central Hospital of Lishui City
See details and how to joinNCT06792786 - Phase 4Not yet taking people in ChinaEsomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
- Where
- Lanzhou
- Age
- 18 years to 80 years
- People
- 120
- Run by
- LanZhou University
See details and how to joinNCT07312370 - Phase 2Taking peopleKC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Beijing Konruns Pharmaceutical Co., Ltd.
See details and how to joinNCT07481058 - Phase 2Not yet taking people in ChinaEvaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT07486310 - Phase 2Taking peoplePhase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 48
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07277439 - Phase 2Taking peopleDisitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 124
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07474324 - Phase 2Taking peopleCarilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Shandong Tumor Hospital
See details and how to joinNCT07320586 - No phaseTaking peopleDevelopment and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
- Where
- Hangzhou, Jiaxing, Lishui
- Age
- 18 years and over
- People
- 5,000
- Run by
- Zhejiang University
See details and how to joinNCT07104214 - No phaseTaking peopleThe Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
- Where
- Hangzhou
- Age
- 18 years to 85 years
- People
- 400
- Run by
- Jichao Qin
See details and how to joinNCT07139418 - No phaseTaking peopleCombination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
- Where
- Beijing, Hangzhou, Jinjiang, Lishui, Taizhou
- Age
- 18 years and over
- People
- 410
- Run by
- Zhejiang University
See details and how to joinNCT07175155 - Phase 2Taking peopleEfficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 46
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07457528 - No phaseTaking peopleIntegrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
- Where
- Wuhan
- People
- 1,500
- Run by
- Shu Peng
See details and how to joinNCT07354295 - Phase 3Taking peopleLaparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
- Where
- Qingdao
- Age
- 18 years to 80 years
- People
- 616
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT05871099 - Phase 2Taking peopleA Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
- Where
- Nanjing
- Age
- 18 years and over
- People
- 28
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07455019 - Phase 1Taking peopleStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Where
- Beijing, Guangzhou, Hangzhou, Harbin, Hefei, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 330 worldwide
- Run by
- I-Mab Biopharma US Limited
See details and how to joinNCT04900818 - Phase 2Taking peopleEfficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Zekuan Xu
See details and how to joinNCT06461910 - No phaseEnrolling by invitationEarly Postoperative Intervention in Gastric Cancer Patients
- Where
- Jinan
- Age
- 18 years to 80 years
- People
- 264
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07444099 - Phase 2Taking peopleInduction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06452602 - Phase 3Taking peopleA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Where
- Baise City, Beijing, Bengbu, Changchun, Changsha, Changzhi, Changzhou, Chengdu, Chongqing, Dezhou, Fuzhou, Guangdong, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Liuzhou, Luoyang, Mianyang, Nanchang, Nanjing, Qingdao, Shanghai, Shaoyang, Shenyang, Shijia Zhuang, Taiyuan, Tianjin, Ürümqi, Xiamen, Xining, Xuzhou, Yichang, Yinchuan, Zhengzhou
- Age
- 18 years and over
- People
- 550 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06532006 · EU 2024-516633-12-00 - Phase 2Taking peopleExploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Nanjing
- Age
- 70 years and over
- People
- 22
- Run by
- Jiangsu Cancer Institute & Hospital
See details and how to joinNCT07435454 - Phase 2Taking peopleNeoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
- Where
- Putian
- Age
- 18 years to 75 years
- People
- 42
- Run by
- The Affiliated Hospital of Putian University
See details and how to joinNCT07437898 - No phaseNot yet taking people in ChinaAn Observational Study on Gastric Cancer in High-risk Individuals
- Where
- Tongling
- Age
- 40 years and over
- People
- 3,000
- Run by
- Fudan University
See details and how to joinNCT07438418 - No phaseNot yet taking people in ChinaClinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging
- Where
- Chongqing
- Age
- 18 years and over
- People
- 50
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07440212 - No phaseTaking peopleAn Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
- Where
- Tongling
- Age
- 40 years and over
- People
- 3,000
- Run by
- Fudan University
See details and how to joinNCT06896370